List of works - Antonella Bacchiocchi

A Serum Protein Signature Associated with Outcome After Anti-PD1 Therapy in Metastatic Melanoma.

scientific article published on 5 December 2017

A novel anti-melanoma SRC-family kinase inhibitor

Abstract LB-104: Excited electrons in melanin induce cyclobutane dimers in the dark

Clonal growth of human melanocytes using cell-free extracellular matrix

scientific article published on 19 September 2013

Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies ⬇️

scientific article published on May 11, 2011

Early B cell changes predict autoimmunity following combination immune checkpoint blockade

scientific article published on 8 January 2018

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas

scientific article published on 27 July 2015

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

scientific article

GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation

scientific article published on 27 July 2016

Genotype-selective combination therapies for melanoma identified by high-throughput drug screening

scientific article published on 13 December 2012

Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors

scientific article

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.

scientific article

Integrated analysis of tumor samples sheds light on tumor heterogeneity

scientific article

Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications

scientific article

Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells

scientific article published on 22 December 2016

MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL.

scientific article published on 21 May 2013

MicroRNA signatures differentiate melanoma subtypes

scientific article

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells

scientific article

Phosphoproteomic screen identifies potential therapeutic targets in melanoma

scientific article

Photochemistry. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure

scientific article

Plasma Markers for Identifying Patients with Metastatic Melanoma ⬇️

scientific article published on April 12, 2011

Pre-treatment patient selection for nivolumab benefit based on serum mass spectra

scientific article published on 4 November 2015

Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors

scientific article published on April 2012

SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer

scientific article

Single-cell cytokine profiling of tumor-infiltrating T cells to measure patient responses to anti-PD-1 therapy. ⬇️

scholarly article

List of works by Antonella Bacchiocchi

A Serum Protein Signature Associated with Outcome After Anti-PD1 Therapy in Metastatic Melanoma.

A novel anti-melanoma SRC-family kinase inhibitor

Abstract LB-104: Excited electrons in melanin induce cyclobutane dimers in the dark

Clonal growth of human melanocytes using cell-free extracellular matrix

Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies ⬇️

Early B cell changes predict autoimmunity following combination immune checkpoint blockade

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation

Genotype-selective combination therapies for melanoma identified by high-throughput drug screening

Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.

Integrated analysis of tumor samples sheds light on tumor heterogeneity

Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications

Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells

MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL.

MicroRNA signatures differentiate melanoma subtypes

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells

Phosphoproteomic screen identifies potential therapeutic targets in melanoma

Photochemistry. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure

Plasma Markers for Identifying Patients with Metastatic Melanoma ⬇️

Pre-treatment patient selection for nivolumab benefit based on serum mass spectra

Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors

SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer

Single-cell cytokine profiling of tumor-infiltrating T cells to measure patient responses to anti-PD-1 therapy. ⬇️